Literature DB >> 16136467

Role of type 1 T helper cells in the resolution of acute Streptococcus pneumoniae sinusitis: a mouse model.

Christopher Blair1, Robert M Naclerio, Xiaohong Yu, Kenneth Thompson, Anne Sperling.   

Abstract

BACKGROUND: We examined the importance of the adaptive and innate immune responses in the resolution of an acute bacterial sinus infection in mice.
METHODS: Recombinase-activating gene knockout (RAG-1(-/-)) (no lymphocytes) and C57BL/6 (wild-type) mice were infected with Streptococcus pneumoniae. For determination of the cell type involved, lymphocytes from mice were adoptively transferred into RAG-1(-/-), C57BL/6 (all lymphocytes), B cell-deficient, and T cell-deficient mice. The degree of infection and inflammation was determined by quantification of S. pneumoniae from nasal lavage and analysis of sinus tissue, respectively.
RESULTS: In C57BL/6 mice, both the infection and inflammation resolved in 21 days, whereas neither resolved in RAG-1(-/-) mice. When C57BL/6 lymphocytes were adoptively transferred into RAG-1(-/-) mice, resolution of the infection and inflammation occurred. Mice without B cells were able to clear the infection, whereas mice without T cells could not clear it. In vitro stimulation of the draining lymph nodes of the infected mice by use of heat-killed S. pneumoniae led to the production of interferon (IFN)- gamma. Flow-cytometric analysis of lymphocytes obtained from sinus mucosa and draining lymph nodes showed an increase in the number of type 1 T helper cell-like cells over that in control mice.
CONCLUSIONS: RAG-1(-/-) mice with innate immunity but no lymphocytes contain--but cannot clear--a bacterial sinus infection. Lymphocytes transferred to RAG-1(-/-) mice clear the infection. The sinus mucosa and draining lymph nodes show an increase in T cells generating IFN- gamma. These data demonstrate that T cells are essential in clearing an acute S. pneumoniae bacterial sinus infection.

Entities:  

Mesh:

Year:  2005        PMID: 16136467     DOI: 10.1086/444544

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice.

Authors:  Yulan Qiu; Xuemei Zhang; Hong Wang; Xinyuan Zhang; Yunjun Mo; Xiaoyu Sun; Jichao Wang; Yibing Yin; Wenchun Xu
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

Review 2.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

3.  Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis.

Authors:  Nicole A Abreu; Nabeetha A Nagalingam; Yuanlin Song; Frederick C Roediger; Steven D Pletcher; Andrew N Goldberg; Susan V Lynch
Journal:  Sci Transl Med       Date:  2012-09-12       Impact factor: 17.956

4.  Lactobacillus rhamnosus GG improves outcome in experimental pseudomonas aeruginosa pneumonia: potential role of regulatory T cells.

Authors:  Ludmila Khailova; Christine H Baird; Aubri A Rush; Eoin N McNamee; Paul E Wischmeyer
Journal:  Shock       Date:  2013-12       Impact factor: 3.454

Review 5.  Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens.

Authors:  Yamilé López Hernández; Daniel Yero; Juan M Pinos-Rodríguez; Isidre Gibert
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

6.  Effect of Shin'iseihaito (Xinyiqingfeitang) on Acute Streptococcus pneumoniae Murine Sinusitis via Macrophage Activation.

Authors:  Masaaki Minami; Toru Konishi; Hiroshi Takase; Zhixia Jiang; Tetsuya Arai; Toshiaki Makino
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-20       Impact factor: 2.629

Review 7.  Manipulation of acute inflammatory lung disease.

Authors:  E L Wissinger; J Saldana; A Didierlaurent; T Hussell
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.